Executive Chairman of $NTRA sold 500 shares in insider sale

$NTRA, the company in focus, recently witnessed an insider sale involving its EXECUTIVE CHAIRMAN, Matthew Rabinowitz. Rabinowitz offloaded 500 shares of $NTRA stock on September 12, 2025, raking in an estimated $86,320 from this transaction. The details of this sale emerged from an official SEC filing. Notably, this sale represented roughly 2.0% of the total shares held by Rabinowitz in this particular class of stock, leaving him with 25,000 shares of $NTRA stock.

Looking at the wider picture of insider trading activity within $NTRA, it is evident that insiders have engaged in a total of 191 transactions on the open market within the last 6 months. Among these transactions, there have been no purchases and a significant 191 sales. The top executives at $NTRA have been actively involved in trading their company’s stock, with figures such as CEO and President, Steven Leonard Chapman, leading the pack with 27 sales amounting to 70,362 shares sold for an approximate value of $10,335,759. Following Chapman is the EXECUTIVE CHAIRMAN himself, Matthew Rabinowitz, who has executed 10 sales to date, offloading 62,436 shares for an estimated $9,738,497.

The trend of insider selling extends across various key individuals within $NTRA, including Jonathan Sheena, Daniel Rabinowitz, Solomon Moshkevich, Gail Boxer Marcus, Michael Burkes Brophy, John Fesko, and Rowan E Chapman, among others. Each of these insiders has engaged in selling a significant number of shares over the last 6 months, showcasing ongoing activity within the company.

Institutional investors have also shown activity in trading $NTRA stock, with 374 institutions adding shares of the company to their portfolios while 329 have decreased their positions in the most recent quarter. Notable moves include JPMorgan Chase & Co. adding 3,263,822 shares, Price T Rowe Associates Inc /MD/ adding 1,650,073 shares, Citadel Advisors LLC removing 1,301,513 shares, Kynam Capital Management LP removing 1,167,570 shares, and Capital World Investors adding 1,013,229 shares, among others.

Additionally, members of Congress have engaged in trading $NTRA stock, with 2 trades occurring in the past 6 months. Notably, Representative Josh Gottheimer has traded $NTRA stock twice, making 1 purchase and 1 sale within this period. Analysts have issued positive ratings for $NTRA, with 6 firms issuing buy ratings on the stock recently. Plus, multiple analysts have provided price targets for $NTRA, with a median target of $214.0 across 6 analysts in the last 6 months.

In conclusion, the recent insider sale involving $NTRA’s EXECUTIVE CHAIRMAN sheds light on ongoing trading activities within the company. The engagement of insiders, institutional investors, members of Congress, and analysts showcases a dynamic environment surrounding $NTRA stock, indicating ongoing interest and activity within the investment community.